retatrutide and heart rate Low dose reta update RETATRUTIDE: A Medication for Diabetes

In DELIVER trail and secondary analysis, dapagliflozin not only reduced the risk of CVD or worsening HF events, but also consistently enhanced overall health and New York Heart Association functional ratings in HFpEF patients [79, 80]

April 2026 JW Pharmaceutical has entered into a licensing agreement with China-based Gan & Lee Pharmaceuticals to obtain exclusive rights in Korea for bofanglutide, an advanced GLP-1 receptor agonist

But very rich or greasy meals may feel heavy for some GLP-1 users

Mo1908: Glucagon-like peptide-1 receptor agonist use in patients with perianal fistulizing Crohn's disease is well tolerated and leads to weight loss and clinical improvement in fistula activity

The following day, the narrative was cemented

[PubMed] [Google Scholar] Hareter A